-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Cingulate's (CING) Buy Rating Reaffirmed at HC Wainwright
Cingulate's (CING) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Cingulate (NASDAQ:CING – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. HC Wainwright also issued estimates for Cingulate's Q4 2022 earnings at ($0.36) EPS, FY2022 earnings at ($1.51) EPS, Q1 2023 earnings at ($0.27) EPS, Q2 2023 earnings at ($0.23) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.25) EPS and FY2023 earnings at ($0.98) EPS.
A number of other research firms have also weighed in on CING. Maxim Group started coverage on Cingulate in a research report on Tuesday, November 22nd. They set a buy rating for the company. Ascendiant Capital Markets started coverage on Cingulate in a research report on Monday, October 3rd. They set a buy rating for the company.
Get Cingulate alerts:Cingulate Stock Up 2.6 %
CING opened at $0.98 on Tuesday. The stock has a market cap of $11.03 million and a PE ratio of -0.66. The business has a 50 day moving average of $0.96 and a 200-day moving average of $1.21. Cingulate has a 52 week low of $0.66 and a 52 week high of $2.48.
Cingulate (NASDAQ:CING – Get Rating) last released its earnings results on Monday, November 14th. The company reported ($0.36) EPS for the quarter.Insiders Place Their Bets
In other Cingulate news, Director Peter J. Werth bought 28,934 shares of Cingulate stock in a transaction on Tuesday, December 13th. The stock was acquired at an average price of $0.98 per share, with a total value of $28,355.32. Following the acquisition, the director now owns 975,165 shares in the company, valued at $955,661.70. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Cingulate news, Director Peter J. Werth bought 28,934 shares of Cingulate stock in a transaction on Tuesday, December 13th. The stock was acquired at an average price of $0.98 per share, with a total value of $28,355.32. Following the acquisition, the director now owns 975,165 shares in the company, valued at $955,661.70. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Gregg Wm Givens bought 85,000 shares of Cingulate stock in a transaction on Tuesday, November 22nd. The stock was acquired at an average cost of $0.88 per share, with a total value of $74,800.00. Following the acquisition, the director now owns 154,318 shares in the company, valued at approximately $135,799.84. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 141,388 shares of company stock valued at $129,998. Corporate insiders own 31.28% of the company's stock.
Institutional Trading of Cingulate
Several large investors have recently modified their holdings of the company. Eagle Asset Management Inc. grew its holdings in shares of Cingulate by 124.5% in the third quarter. Eagle Asset Management Inc. now owns 107,527 shares of the company's stock worth $115,000 after acquiring an additional 59,632 shares during the period. Creative Planning bought a new stake in shares of Cingulate in the second quarter worth $34,000. Finally, Renaissance Technologies LLC bought a new stake in shares of Cingulate in the first quarter worth $100,000. Institutional investors own 2.35% of the company's stock.
About Cingulate
(Get Rating)
Cingulate Inc, a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders.
Recommended Stories
- Get a free copy of the StockNews.com research report on Cingulate (CING)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for Cingulate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cingulate and related companies with MarketBeat.com's FREE daily email newsletter.
HC Wainwright reiterated their buy rating on shares of Cingulate (NASDAQ:CING – Get Rating) in a research note issued to investors on Tuesday, The Fly reports. HC Wainwright also issued estimates for Cingulate's Q4 2022 earnings at ($0.36) EPS, FY2022 earnings at ($1.51) EPS, Q1 2023 earnings at ($0.27) EPS, Q2 2023 earnings at ($0.23) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.25) EPS and FY2023 earnings at ($0.98) EPS.
HC 溫賴特重申他們對股票的買入評級 扣 (納斯達克:嵌 — 獲得評分) 在週二發給投資者的一份研究報告中，《飛行》報導。韋賴特還發布了古納爾 2022 年第四季盈利為每股盈利（0.36 美元）、FY2022 盈利為每股盈利（1.51 美元）、2023 年第一季每股盈利（0.27 美元）、2023 年第二季盈利（0.23 美元）、2023 年第三季盈利（0.24 美元）盈利（0.24 美元）、2023 年第四季盈利（0.25 美元）盈利（FY2023 盈利）。
A number of other research firms have also weighed in on CING. Maxim Group started coverage on Cingulate in a research report on Tuesday, November 22nd. They set a buy rating for the company. Ascendiant Capital Markets started coverage on Cingulate in a research report on Monday, October 3rd. They set a buy rating for the company.
一些其他研究公司也對 GING 進行了稱重。美心集團於 11 月 22 日（星期二）在一份研究報告中開始報導 Cingulate。他們為公司設置了購買評級。優勢資本市場於 10 月 3 日（星期一）在一份研究報告中開始對扣帶進行報導。他們為公司設置了購買評級。
Cingulate Stock Up 2.6 %
結合股票上漲 2.6%
CING opened at $0.98 on Tuesday. The stock has a market cap of $11.03 million and a PE ratio of -0.66. The business has a 50 day moving average of $0.96 and a 200-day moving average of $1.21. Cingulate has a 52 week low of $0.66 and a 52 week high of $2.48.
星期二，星期二以 0.98 美元開盤。該股的市值為 1103 萬美元，私募股比率為 -0.66。該業務的移動平均線為 50 美元，200 天移動平均線為 1.21 美元。扣帶有 52 周低點 0.66 美元，52 周高點為 2.48 美元。
Insiders Place Their Bets
內部人士下注
In other Cingulate news, Director Peter J. Werth bought 28,934 shares of Cingulate stock in a transaction on Tuesday, December 13th. The stock was acquired at an average price of $0.98 per share, with a total value of $28,355.32. Following the acquisition, the director now owns 975,165 shares in the company, valued at $955,661.70. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Cingulate news, Director Peter J. Werth bought 28,934 shares of Cingulate stock in a transaction on Tuesday, December 13th. The stock was acquired at an average price of $0.98 per share, with a total value of $28,355.32. Following the acquisition, the director now owns 975,165 shares in the company, valued at $955,661.70. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Gregg Wm Givens bought 85,000 shares of Cingulate stock in a transaction on Tuesday, November 22nd. The stock was acquired at an average cost of $0.88 per share, with a total value of $74,800.00. Following the acquisition, the director now owns 154,318 shares in the company, valued at approximately $135,799.84. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 141,388 shares of company stock valued at $129,998. Corporate insiders own 31.28% of the company's stock.
在其他扣帶消息中，董事彼得 ·J· 沃思在 12 月 13 日（星期二）的一項交易中購買了 28,934 股淨股。該股票以每股 0.98 美元的平均價格獲得，總價值為 28,355.32 美元。收購後，董事現在擁有該公司 975,165 股股份，價值 955,661.70 美元。購買在與 SEC 的文件中披露，可以通過以下方式訪問 此超連結。在其他扣帶消息中，董事彼得 ·J· 沃思在 12 月 13 日（星期二）的一項交易中購買了 28,934 股淨股。該股票以每股 0.98 美元的平均價格獲得，總價值為 28,355.32 美元。收購後，董事現在擁有該公司 975,165 股股份，價值 955,661.70 美元。購買在與 SEC 的文件中披露，可以通過以下方式訪問 此超連結。此外，董事格雷格·韋姆·吉文斯在 11 月 22 日（星期二）的一項交易中購買了 85,000 股扣帶股票。該股票以每股 0.88 美元的平均成本獲得，總價值為 74,800.00 美元。收購後，董事現擁有該公司 154,318 股股份，價值約為 135,799.84 美元。可以找到此次購買的披露 這裡。在上個季度，內部人士收購了價值 129,998 美元的公司股票 141,388 股。企業內部人士擁有公司股票的 31.28%。
Institutional Trading of Cingulate
扣合金的機構交易
Several large investors have recently modified their holdings of the company. Eagle Asset Management Inc. grew its holdings in shares of Cingulate by 124.5% in the third quarter. Eagle Asset Management Inc. now owns 107,527 shares of the company's stock worth $115,000 after acquiring an additional 59,632 shares during the period. Creative Planning bought a new stake in shares of Cingulate in the second quarter worth $34,000. Finally, Renaissance Technologies LLC bought a new stake in shares of Cingulate in the first quarter worth $100,000. Institutional investors own 2.35% of the company's stock.
一些大型投資者最近修改了他們對該公司的持有權。鷹資產管理股份有限公司在第三季度增長了 124.5％ 的持有量。鷹資產管理股份有限公司現在擁有該公司股票的 107,527 股，價值 115,000 美元，期內另外收購 59,632 股股份。創意規劃在第二季度購買了價值 34,000 美元的新股份 Cingulate 股份。最後，文藝復興技術有限責任公司在第一季度購買了新股份的 Cingulate 股份，價值 100,000 美元。機構投資者擁有公司股票的 2.35%。
About Cingulate
關於扣結
(Get Rating)
(取得評分)
Cingulate Inc, a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders.
Cingulate Inc 是一家臨床階段的生物製藥公司，致力於開發用於治療注意力不足/過度活躍障礙的候選產品。該公司的主要候選產品包括 CTX-1301（右甲基苯酸酯），該試驗處於 3 期臨床試驗中，以及用於治療注意力缺陷/過度活躍障礙的 CTX-1302（右旋安非他明）。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on Cingulate (CING)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
- 獲取有關扣帶的研究報告的免費副本
- 市場節拍週的回顧 — 1/16 — 1/20
- 老自治領是否顯示卡車正在擊中剎車？
- 諾德斯特龍將對減價的恐懼放入零售業
- 埃克森美孚股票：在買入點的醒目距離內
- 高股息收益的必和必拓認為中國推動 23 年增長
Receive News & Ratings for Cingulate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cingulate and related companies with MarketBeat.com's FREE daily email newsletter.
接收《扣留日報》的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Cingulate 和相關公司的最新新聞和分析師評級的簡要每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧